My Queue

There are no Videos in your queue.

Click on the Add to next to any video to save to your queue.

There are no Articles in your queue.

Click on the Add to next to any article to save to your queue.

There are no Podcasts in your queue.

Click on the Add to next to any podcast episode to save to your queue.

You're not following any authors.

Click the Follow button on any author page to keep up with the latest content from your favorite authors.

News and Trends

'Pharma Bro' Martin Shkreli Arrested on Securities Fraud Charges

'Pharma Bro' Martin Shkreli Arrested on Securities Fraud Charges
Image credit: Getty Images
1 min read
This story originally appeared on Fortune Magazine

Martin Shkreli, the now-notorious CEO of Turing Pharmaceuticals, has been arrested on suspicion of securities fraud, according to Bloomberg News.

Shkreli, 32, became infamous earlier this year when he drastically raised the price of a drug taken by AIDS patients, but Bloomberg said the case against him is unrelated to that.

Instead, prosecutors have charged him with illegally taking stock from Retrophin Inc., a biotech firm which he founded in 2011, and using it to pay off unrelated business debts, Bloomberg said.

Shkreli’s hedge fund MSMB Capital Management suffered heavy losses as a result of the fraud, the agency added, referring also to allegations of “secret payoffs” and “sham consulting arrangements.”

Tom Brady Launches a Sports Media Startup